You are required to be logged in to access the full website
Click here if you have forgotten your username or password
29 July 2026 - Clinical-stage biotechnology company AbCellera Biologics Inc (Nasdaq:ABCL) announced on Wednesday that it has entered into a collaboration with biopharmaceutical company Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) to research, de...
29 July 2026 - Biopharmaceutical company Incyte (Nasdaq:INCY) announced on Wednesday that the European Commission has approved Opzelura (ruxolitinib) cream for adults with moderate atopic dermatitis who have an inadequate response to or cannot use to...
29 July 2026 - Biopharmaceutical company Synlogic Inc (OTC:SYBX) and Caldera Therapeutics Inc, a privately held clinical-stage biotechnology company announced on Wednesday that they have entered into a definitive an all-stock merger agreement to comb...
29 July 2026 - Life sciences investment company RTW Biotech Opportunities Ltd (LSE: RTW) announced on Wednesday that portfolio company Yarrow Bioscience has completed its merger with VYNE Therapeutics Inc and begun trading on the Nasdaq Global Select...
29 July 2026 - Biopharmaceutical group Hemogenyx Pharmaceuticals plc (LSE: HEMO) reported on Wednesday that it has signed a letter of intent with the National Cancer Centre at Vilnius University Hospital Santaros Klinikos to establish a scientific an...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe